$59.11
2.96% day before yesterday
Nasdaq, Sep 06, 10:01 pm CET
ISIN
US30063P1057
Symbol
EXAS
Sector
Industry

Exact Sciences Corporation Stock price

$59.11
+3.15 5.63% 1M
+2.84 5.05% 6M
-14.87 20.10% YTD
-23.06 28.06% 1Y
-48.87 45.26% 3Y
-61.75 51.09% 5Y
+36.97 166.98% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
-1.80 2.96%
ISIN
US30063P1057
Symbol
EXAS
Sector
Industry

Key metrics

Market capitalization $10.92b
Enterprise Value $12.76b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 4.88
P/S ratio (TTM) P/S ratio 4.18
P/B ratio (TTM) P/B ratio 3.42
Revenue growth (TTM) Revenue growth 13.54%
Revenue (TTM) Revenue $2.61b
EBIT (operating result TTM) EBIT $-281.08m
Free Cash Flow (TTM) Free Cash Flow $-14.96m
Cash position $946.78m
EPS (TTM) EPS $-0.96
P/E forward negative
P/S forward 3.86
EV/Sales forward 4.51
Short interest 7.55%
Show more

Is Exact Sciences Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Exact Sciences Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Exact Sciences Corporation forecast:

21x Buy
88%
3x Hold
13%

Analyst Opinions

24 Analysts have issued a Exact Sciences Corporation forecast:

Buy
88%
Hold
13%

Financial data from Exact Sciences Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
2,612 2,612
14% 14%
100%
- Direct Costs 793 793
13% 13%
30%
1,819 1,819
14% 14%
70%
- Selling and Administrative Expenses 1,421 1,421
3% 3%
54%
- Research and Development Expense 458 458
19% 19%
18%
-61 -61
64% 64%
-2%
- Depreciation and Amortization 221 221
1% 1%
8%
EBIT (Operating Income) EBIT -281 -281
28% 28%
-11%
Net Profit -175 -175
59% 59%
-7%

In millions USD.

Don't miss a Thing! We will send you all news about Exact Sciences Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Exact Sciences Corporation Stock News

Neutral
Seeking Alpha
3 days ago
Exact Sciences Corporation (NASDAQ:EXAS ) Wells Fargo 2024 Healthcare Conference September 5, 2024 3:45 PM ET Company Participants Aaron Bloomer - Chief Financial Officer Conference Call Participants Brandon Couillard - Wells Fargo Brandon Couillard Alright, folks. We'll go ahead and get started.
Neutral
Business Wire
11 days ago
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast. Wells Fargo Healthcare Conference, Boston Fireside chat on Wednesday, September 4, 2024 at 3:45 p.m. ET Baird Global Healthcare Conf...
Positive
Seeking Alpha
20 days ago
Exact Sciences stock is down 35% since August 2021, now trading at around $58.75. The second quarter of 2024 (Q2) results beat expectations with revenue growth driven by the Cologuard screening segment. It raised adjusted EBITDA guidance for 2024, demonstrating confidence in continued sales momentum and profitability.
More Exact Sciences Corporation News

Company Profile

EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.

Head office United States
CEO Kevin Conroy
Employees 6,600
Founded 1995
Website www.exactsciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today